News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
284,704 Results
Type
Article (15314)
Company Profile (292)
Press Release (269098)
Section
Business (83092)
Career Advice (389)
Deals (13918)
Drug Delivery (38)
Drug Development (50887)
Employer Resources (45)
FDA (5954)
Job Trends (5782)
News (149721)
Policy (10431)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (4)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (1037)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (23004)
ALS (61)
Alzheimer's disease (862)
Antibody-drug conjugate (ADC) (88)
Approvals (5970)
Artificial intelligence (128)
Autoimmune disease (13)
Automation (6)
Bankruptcy (105)
Best Places to Work (5208)
BIOSECURE Act (5)
Biosimilars (41)
Biotechnology (240)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (144)
Cancer (1336)
Cardiovascular disease (113)
Career advice (329)
Career pathing (7)
CAR-T (107)
Cell therapy (309)
Cervical cancer (8)
Clinical research (41250)
Collaboration (521)
Compensation (232)
Complete response letters (13)
COVID-19 (1072)
CRISPR (37)
C-suite (151)
Cystic fibrosis (77)
Data (1407)
Denatured (11)
Depression (29)
Diabetes (130)
Diagnostics (1544)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (80)
Drug pricing (30)
Drug shortages (5)
Duchenne muscular dystrophy (84)
Earnings (30407)
Editorial (19)
Employer branding (4)
Employer resources (42)
Events (49994)
Executive appointments (432)
FDA (6601)
Featured Employer (38)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (485)
Gene editing (91)
Generative AI (10)
Gene therapy (238)
GLP-1 (367)
Government (1161)
Grass and pollen (2)
Guidances (21)
Healthcare (7002)
Huntington's disease (21)
IgA nephropathy (21)
Immunology and inflammation (81)
Indications (18)
Infectious disease (1135)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (58)
Interviews (73)
IPO (7508)
IRA (11)
Job creations (918)
Job search strategy (270)
Kidney cancer (6)
Labor market (5)
Layoffs (205)
Leadership (4)
Legal (1463)
Liver cancer (30)
Lung cancer (191)
Lymphoma (85)
Machine learning (1)
Management (10)
Manufacturing (126)
MASH (49)
Medical device (3052)
Medtech (3053)
Mergers & acquisitions (6720)
Metabolic disorders (375)
Multiple sclerosis (54)
NASH (13)
Neurodegenerative disease (62)
Neuropsychiatric disorders (23)
Neuroscience (1248)
NextGen: Class of 2025 (2273)
Non-profit (1119)
Northern California (1610)
Now hiring (21)
Obesity (194)
Opinion (111)
Ovarian cancer (60)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (114)
Partnered (10)
Patents (113)
Patient recruitment (67)
Peanut (35)
People (26615)
Pharmaceutical (49)
Pharmacy benefit managers (6)
Phase I (14518)
Phase II (19161)
Phase III (12193)
Pipeline (750)
Podcasts (48)
Policy (39)
Postmarket research (866)
Preclinical (6110)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (279)
Real estate (1588)
Recruiting (19)
Regulatory (8839)
Reports (15)
Research institute (1022)
Resumes & cover letters (64)
Rett syndrome (4)
RNA editing (4)
RSV (11)
Schizophrenia (58)
Series A (96)
Series B (60)
Service/supplier (1)
Sickle cell disease (39)
Southern California (1425)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (15)
Startups (2062)
State (1)
Stomach cancer (4)
Supply chain (20)
Tariffs (4)
The Weekly (36)
United States (12704)
Vaccines (208)
Venture capitalists (29)
Webinars (7)
Weight loss (108)
Women's health (15)
Worklife (4)
Date
Today (71)
Last 7 days (461)
Last 30 days (1674)
Last 365 days (20597)
2025 (5068)
2024 (21196)
2023 (23188)
2022 (28637)
2021 (30693)
2020 (26139)
2019 (17955)
2018 (12964)
2017 (14504)
2016 (12571)
2015 (15094)
2014 (10919)
2013 (7949)
2012 (8123)
2011 (8169)
2010 (7765)
Location
Africa (191)
Alabama (39)
Alaska (4)
Arizona (58)
Arkansas (5)
Asia (17796)
Australia (3027)
California (3680)
Canada (1077)
China (329)
Colorado (139)
Connecticut (149)
Delaware (89)
Europe (38740)
Florida (432)
Georgia (119)
Idaho (17)
Illinois (226)
India (9)
Indiana (144)
Iowa (2)
Japan (75)
Kansas (61)
Kentucky (6)
Louisiana (3)
Maine (11)
Maryland (461)
Massachusetts (2907)
Michigan (71)
Minnesota (154)
Mississippi (1)
Missouri (29)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (899)
New Mexico (13)
New York (988)
North Carolina (542)
North Dakota (5)
Northern California (1610)
Ohio (125)
Oklahoma (10)
Oregon (23)
Pennsylvania (689)
Puerto Rico (3)
Rhode Island (17)
South America (253)
South Carolina (5)
Southern California (1425)
Tennessee (27)
Texas (427)
Utah (50)
Virginia (72)
Washington D.C. (30)
Washington State (330)
Wisconsin (15)
284,704 Results for "solve therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Solve Therapeutics, Inc. Acquires Cereius, Inc., a Duke University Spin-Out
Solve Therapeutics, Inc. announces the acquisition of Cereius, Inc.
June 22, 2023
·
4 min read
Press Releases
Avantor® Opens New Bridgewater Innovation Center Focused on Solving Life Science’s Biggest Challenges
November 15, 2024
·
2 min read
Press Releases
PharmaTher Provides Complete Response Amendment for US FDA New Drug Application for Ketamine
Expecting FDA approval of Ketamine in Q2-2025 Solving the shortage problem of Ketamine and unlocking its pharmaceutical potential
March 3, 2025
·
5 min read
Press Releases
Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem
March 12, 2025
·
8 min read
Press Releases
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
September 11, 2024
·
7 min read
Business
Nerviano Medical Sciences Announces Licensing of Linker-Payload Technology to Solve Therapeutics to Develop and Commercialize Novel Antibody-Drug Conjugates.
Nerviano Medical Sciences S.r.l. (NMS) announced signing of a license agreement and right of option with Solve Therapeutics, Inc. (SolveTx) to develop and commercialize novel antibody-drug conjugates (ADCs) for up to four cancer targets selected by SolveTx.
June 5, 2023
·
6 min read
Biotech Bay
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced the creation of the HiFi Solves consortium.
November 2, 2023
·
6 min read
DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogy
QIAGEN and DNA Labs International announced that DLI has recently solved two decades-old “cold cases” using QIAGEN solutions.
November 30, 2023
·
9 min read
SOLVE FSHD Announces New Collaborative Research Grants to Accelerate Novel Potential Therapeutics for Facioscapulohumeral Muscular Dystrophy (FSHD)
SOLVE FSHD, a venture philanthropy organization catalyzing innovation and removing barriers to accelerate new therapies for FSHD, announced today that it has awarded grants totalling USD $1.4M to four new collaborative research projects that address critical gaps in FSHD therapeutics, biology and/or biomarkers.
July 11, 2023
·
3 min read
Bio NC
Bright Path Labs is Solving Drug Shortages with Domestic Development and Manufacturing of Cancer Medicines
Bright Path Laboratories, a US-based advanced drug development and manufacturing company is proud to announce their contribution to solving drug shortages for the domestic development and manufacturing of two critical cancer drugs: Carboplatin and Cisplatin.
December 13, 2023
·
1 min read
1 of 28,471
Next
